IL1β is a widely studied pro-inflammatory cytokine [40], and a large number of studies have confirmed that IL1β is involved in the development of NAFLD/NASH [41,42]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.